Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report

1 Nov 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Viral gastroenteritis research and epidemiology
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37949751
DOI: 10.1016/j.vaccine.2023.10.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPMID 37949751Read ↗

Current Developments and Challenges of mRNA VaccinesSemantic proximity Read ↗

mRNA vaccines for infectious diseases: principles, delivery and clinical translationSemantic proximity Read ↗

mRNA Vaccine Technology Beyond COVID-19Semantic proximity Read ↗

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read ↗

mRNA cancer vaccines: Advances, trends and challengesSemantic proximity Read ↗

mRNA vaccine development and applications: A special focus on tumors (Review)Semantic proximity Read ↗

Mucosal mRNA Vaccines. Merits and PerspectivesSemantic proximity Read ↗

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read ↗

mRNA vaccines: the most recent clinical applications of synthetic mRNASemantic proximity Read ↗

mRNA-based therapeutics: looking beyond COVID-19 vaccinesSemantic proximity Read ↗

mRNA-based modalities for infectious disease managementSemantic proximity Read ↗

Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.